Actuate Therapeutics, Inc. (ACTU)

NASDAQ: ACTU · Real-Time Price · USD

2.900

+0.050 (1.75%)

At close: Apr 28, 2026, 4:00 PM EDT

2.800

-0.100 (-3.45%)

Pre-market: Apr 29, 2026, 4:31 AM EDT

Actuate Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	13.16	8.64	2.96	20.45
Cash & Short-Term Investments	13.16	8.64	2.96	20.45
Cash Growth	52.28%	192.08%	-85.53%	-
Prepaid Expenses	0.48	0.57	0.04	0.03
Total Current Assets	13.64	9.21	3	20.48
Long-Term Deferred Charges	0.39	0.11	-	-
Total Assets	14.04	9.32	3	20.48
Accounts Payable	1.52	1.92	3.42	2.13
Accrued Expenses	4.18	6.88	3.5	2.21
Total Current Liabilities	5.71	8.8	6.92	4.34
Other Long-Term Liabilities	0.4	0.41	0.54	0.49
Total Liabilities	6.11	9.21	7.46	4.84
Common Stock	0	0	0	0
Additional Paid-In Capital	162.53	132.48	5.47	5.04
Retained Earnings	-154.61	-132.38	-105.09	-80.35
Total Common Equity	7.92	0.1	-99.63	-75.31
Shareholders' Equity	7.92	0.1	-4.46	15.65
Total Liabilities & Equity	14.04	9.32	3	20.48
Net Cash (Debt)	13.16	8.64	2.96	20.45
Net Cash Growth	52.28%	192.08%	-85.53%	-
Net Cash Per Share	0.63	1.03	2.06	16.89
Filing Date Shares Outstanding	23.71	19.53	1.69	1.21
Total Common Shares Outstanding	23.25	19.53	1.69	1.21
Working Capital	7.94	0.41	-3.93	16.14
Book Value Per Share	0.34	0.01	-58.93	-62.21
Tangible Book Value	7.92	0.1	-99.63	-75.31
Tangible Book Value Per Share	0.34	0.01	-58.93	-62.21

Source: S&P Capital IQ. Standard template. Financial Sources.